← back to search

Wei Wu

Anhui Agricultural University · CN
Area of research
Oncology · Immunology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Hepatocellular Carcinoma Treatment and Prognosis, and Breast Cancer Treatment Studies.
h-index
29
citations
4,305
works
132
NIH funding
primary concept
email

Recent publications

CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype
Oncogene 2022cited by 82position: middledoi
Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients
Frontiers in Oncology 2022cited by 45position: middledoi
Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
˜The œLancet. Gastroenterology & hepatology 2021cited by 250position: middledoi
The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis
Nature Communications 2021cited by 195position: middledoi
Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer
Nature Communications 2020cited by 187position: middledoi
Identification of TP53 mutation associated-immunotype and prediction of survival in patients with hepatocellular carcinoma
Annals of Translational Medicine 2020cited by 12position: middledoi
Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy
Clinical Cancer Research 2019cited by 164position: middledoi
Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis
BMC Cancer 2019cited by 110position: middledoi
Altered Regional Homogeneity in Patients With Corneal Ulcer: A Resting-State Functional MRI Study
Frontiers in Neuroscience 2019cited by 23position: middledoi
Altered spontaneous brain activity patterns in patients with corneal ulcer using amplitude of low‑frequency fluctuation: An fMRI study
Experimental and Therapeutic Medicine 2019cited by 15position: middledoi
LncRNA NKILA suppresses TGF‐β‐induced epithelial–mesenchymal transition by blocking NF‐κB signaling in breast cancer
International Journal of Cancer 2018cited by 129position: firstdoi
Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine–Paracrine Loop
Clinical Cancer Research 2018cited by 95position: middledoi
Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer
Cell Research 2017cited by 225position: middledoi
Epstein–Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages
Cancer Research 2017cited by 92position: middledoi
CXCL6 promotes non-small cell lung cancer cell survival and metastasis via down-regulation of miR-515-5p
Biomedicine & Pharmacotherapy 2017cited by 69position: middledoi
Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting<i>NF-κB</i>gene transcription
World Journal of Hepatology 2016cited by 28position: firstdoi
Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target
Oncotarget 2016cited by 22position: middledoi
Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma
Tumor Biology 2015cited by 19position: middledoi
A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
Cancer Cell 2014cited by 779position: middledoi
Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma
Hepatobiliary & pancreatic diseases international 2013cited by 49position: middledoi
Inhibition of autocrine IGF-II on effect of human HepG2 cell proliferation and angiogenesis factor expression
Tumor Biology 2012cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Erwei Song · Southern Medical University6 papers (2014–2022)Herui Yao · Cancer Clinic5 papers (2014–2021)Jianing Chen · Tongji University5 papers (2014–2021)Di Huang · Fu Wai Hospital5 papers (2014–2022)Dengfu Yao · Nantong University5 papers (2012–2016)Wenli Sai · Nantong University4 papers (2012–2016)Liwei Qiu · Nantong University4 papers (2012–2016)Min Yao · Shandong University of Traditional Chinese Medicine4 papers (2013–2016)Yandan Yao · First Affiliated Hospital of Xi'an Jiaotong University4 papers (2019–2022)Shicheng Su · First Affiliated Hospital of Zhengzhou University4 papers (2014–2018)Ling Lin · Huazhong University of Science and Technology3 papers (2014–2018)Fengxi Su · Sun Yat-sen University3 papers (2014–2018)Junling Yang · Nantong University3 papers (2013–2016)Xiaorong Lin · Fujian Medical University3 papers (2019–2021)Wenkui Fu · Sun Yat-sen University3 papers (2019–2021)Jiewen Chen · Center for Excellence in Molecular Cell Science3 papers (2019–2021)Haijian Zhang · Nantong University3 papers (2012–2020)Zhizhen Dong · Nantong University2 papers (2012–2016)Chonghua He · Shenzhen Luohu People's Hospital2 papers (2014–2017)Yi Shao · Genesee Community College2 papers (2019–2019)